Human papilloma virus (HPV) profiles in breast cancer: future management.
Breast cancer (BC)
HPV transmission
human papillomavirus (HPV)
management
Journal
Annals of translational medicine
ISSN: 2305-5839
Titre abrégé: Ann Transl Med
Pays: China
ID NLM: 101617978
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
entrez:
23
6
2020
pubmed:
23
6
2020
medline:
23
6
2020
Statut:
ppublish
Résumé
Breast cancer (BC) is frequent among women in worldwide as well as in India. Several studies have reported a wide variation (1.6-86.2%) in the frequency of incidence of human papillomavirus (HPV) infection in BC with high prevalence of high risk HPV16 subtype. HPV infection in breast can occur through different routes like body fluid or by micro-lesion of breast skin from genital/agential sites, though the actual mode of HPV transmission is not yet known in details. Frequent integration and sequence variation with low copy number of HPV16 were seen in this tumour. In addition, high frequencies of methylation in p97 promoter region of HPV16 were evident in this tumour. Novel splice variants of E6/E7 along with other common variants and their protein expression were seen in the tumour. This indicates the importance of HPV in this tumor, its early diagnosis and prognosis. Thus, HPV may be targeted through vaccination to control the disease. However, detailed analysis of HPV associated molecular pathogenesis of BC is warranted for proper therapeutic intervention.
Identifiants
pubmed: 32566587
doi: 10.21037/atm-19-2756
pii: atm-08-10-650
pmc: PMC7290605
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
650Informations de copyright
2020 Annals of Translational Medicine. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-19-2756). The authors have no conflicts of interest to declare.
Références
Curr Mol Med. 2016 Aug 05;:
pubmed: 27494032
Cancer Res. 2000 Sep 15;60(18):4993-5001
pubmed: 11016617
Br J Cancer. 2008 Aug 5;99(3):408-14
pubmed: 18648364
Infect Agent Cancer. 2011 Jun 23;6(1):7
pubmed: 21699721
PLoS One. 2014 Mar 10;9(3):e90343
pubmed: 24614680
J Clin Virol. 2004 Dec;31(4):292-7
pubmed: 15494272
BMC Cancer. 2019 Jan 14;19(1):61
pubmed: 30642295
PLoS One. 2017 Feb 28;12(2):e0172760
pubmed: 28245287
J Virol. 2001 Feb;75(3):1565-70
pubmed: 11152531
PLoS One. 2013 Apr 25;8(4):e61613
pubmed: 23637866
PLoS One. 2012;7(11):e48788
pubmed: 23183846
Pediatr Infect Dis J. 2017 Jul;36(7):627-630
pubmed: 28604561
Front Oncol. 2015 Dec 16;5:277
pubmed: 26734565
Cancer Res. 2008 Apr 15;68(8):2622-31
pubmed: 18413729
Breast Cancer Res Treat. 2008 May;109(1):55-8
pubmed: 17624590
J Clin Microbiol. 2005 Nov;43(11):5428-34
pubmed: 16272465
Front Oncol. 2016 Jan 08;5:298
pubmed: 26779441
PLoS One. 2014 May 23;9(5):e97787
pubmed: 24858917
Rev Med Virol. 2015 Mar;25 Suppl 1:2-23
pubmed: 25752814
Clin Infect Dis. 1999 Jan;28 Suppl 1:S37-56
pubmed: 10028109
Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3687-91
pubmed: 7537374
Virology. 2002 Aug 1;299(2):279-287
pubmed: 12202231
ScientificWorldJournal. 2012;2012:837191
pubmed: 22566779
J Virol. 1998 Mar;72(3):2160-7
pubmed: 9499072
Breast. 2011 Apr;20(2):184-9
pubmed: 21146410
Ecancermedicalscience. 2015 Jun 25;9:548
pubmed: 26180547
Adv Biomed Res. 2014 Jan 27;3:75
pubmed: 24627883
Cochrane Database Syst Rev. 2017 Aug 10;8:CD008587
pubmed: 28796882
J Med Virol. 2013 Dec;85(12):2087-92
pubmed: 23959946
Front Oncol. 2016 Sep 29;6:207
pubmed: 27747193
Med Oncol. 2012 Jun;29(2):521-5
pubmed: 21499926
Breast Cancer Res Treat. 1996;39(2):197-202
pubmed: 8872328
Breast Cancer Res. 2004;6(5):213-8
pubmed: 15318928
Future Microbiol. 2018 Feb;13:187-194
pubmed: 28975808
Breast Cancer (Auckl). 2015 Dec 10;9:93-7
pubmed: 26691275
Infect Agent Cancer. 2016 Mar 14;11:14
pubmed: 26981149
Asian Pac J Cancer Prev. 2014;15(9):4061-5
pubmed: 24935597
Virology. 2004 Feb 5;319(1):152-61
pubmed: 14967496
Biochim Biophys Acta. 1996 Oct 9;1288(2):F55-78
pubmed: 8876633
J Med Virol. 2015 Jun;87(6):1034-40
pubmed: 25676062
BMC Cancer. 2017 May 8;17(1):320
pubmed: 28482874
J Clin Invest. 2007 Nov;117(11):3155-63
pubmed: 17975657
J Exp Clin Cancer Res. 2006 Dec;25(4):515-21
pubmed: 17310842
Cell Cycle. 2007 Aug 15;6(16):2038-42
pubmed: 17721085
PLoS One. 2018 Nov 5;13(11):e0207016
pubmed: 30395655
BMC Cancer. 2009 Jan 22;9:26
pubmed: 19161629
Eur J Gynaecol Oncol. 2012;33(2):164-7
pubmed: 22611956
Breast Cancer. 2000 Jan;7(1):33-6
pubmed: 11029768
Nat Rev Microbiol. 2013 Apr;11(4):239-51
pubmed: 23474685
Br J Cancer. 2001 Aug 3;85(3):398-404
pubmed: 11487272
Pathol Res Pract. 1992 Apr;188(3):384-6
pubmed: 1320761
PLoS One. 2015 Aug 21;10(8):e0136050
pubmed: 26295705
J Biol Chem. 1999 Feb 26;274(9):5810-22
pubmed: 10026203
Int J Mol Sci. 2016 May 13;17(5):
pubmed: 27187374
Curr Pharm Des. 2008;14(22):2159-72
pubmed: 18781969
Breast Cancer Res. 2005;7(1):R1-11
pubmed: 15642157
PLoS Pathog. 2017 Apr 6;13(4):e1006211
pubmed: 28384274
East Mediterr Health J. 2014 Jun 18;20(6):372-7
pubmed: 24960513
Medicina (Kaunas). 2019 Jul 17;55(7):
pubmed: 31319555
Pediatrics. 2000 Oct;106(4):645-9
pubmed: 11015503
Breast Cancer Res Treat. 1999 Jan;53(2):121-35
pubmed: 10326789
Med Oncol. 2012 Mar;29(1):48-55
pubmed: 21318737
J Mol Evol. 2002 Oct;55(4):491-9
pubmed: 12355268
BMC Cancer. 2013 Oct 01;13:445
pubmed: 24083491
J Virol. 1999 Sep;73(9):7297-307
pubmed: 10438818
Virology. 2003 Mar 1;307(1):1-11
pubmed: 12667809
Breast Cancer. 2018 Mar;25(2):127-133
pubmed: 29350329
Anticancer Res. 1999 Nov-Dec;19(6B):5057-61
pubmed: 10697510
J Natl Cancer Inst. 2016 Apr 29;108(9):
pubmed: 27130930
J Biol Chem. 2005 Sep 30;280(39):33165-77
pubmed: 15983032
Anticancer Res. 2015 Feb;35(2):851-6
pubmed: 25667466
Neoplasia. 2005 Aug;7(8):788-98
pubmed: 16207481
Asian Pac J Cancer Prev. ;18(7):1839-1845
pubmed: 28749118
Oncol Lett. 2018 Jul;16(1):317-325
pubmed: 29928417
Sci Rep. 2017 Feb 27;7:43591
pubmed: 28240743
Cancer Treat Res Commun. 2019;19:100122
pubmed: 30785026
N Engl J Med. 1999 Nov 25;341(22):1633-8
pubmed: 10572150
J Int Med Res. 2011;39(5):1636-44
pubmed: 22117964
Nat Rev Cancer. 2002 May;2(5):342-50
pubmed: 12044010
J Med Virol. 2005 Feb;75(2):276-81
pubmed: 15602723
Endocr Relat Cancer. 2005 Sep;12(3):533-48
pubmed: 16172191
Tumour Biol. 2007;28(6):327-32
pubmed: 18391549
Mol Biol Rep. 2009 Apr;36(4):807-12
pubmed: 18427947
Br J Cancer. 1992 Jun;65(6):891-4
pubmed: 1319728
Infect Agent Cancer. 2013 Sep 02;8:32
pubmed: 24138789
Breast Cancer Res Treat. 2009 Mar;114(1):189-94
pubmed: 18373273
Br J Cancer. 2009 Oct 20;101(8):1345-50
pubmed: 19724278
Clinics (Sao Paulo). 2018 Oct 18;73:e465
pubmed: 30365827
Cancer Res. 2010 Jan 15;70(2):575-87
pubmed: 20068186
Virology. 2013 Oct;445(1-2):232-43
pubmed: 23998342
Asia Pac J Clin Oncol. 2017 Aug;13(4):289-295
pubmed: 28181405
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
PLoS One. 2014 Dec 05;9(12):e114559
pubmed: 25478862
Virol J. 2014 Nov 21;11:190
pubmed: 25413873
J Clin Virol. 2018 Sep;106:41-43
pubmed: 30041089
J Clin Virol. 2014 Oct;61(2):255-9
pubmed: 25088618
Breast. 2007 Apr;16(2):172-7
pubmed: 17088061
Breast Cancer Res Treat. 2004 Mar;84(2):131-7
pubmed: 14999143
Clin Biochem. 2006 Jul;39(7):727-31
pubmed: 16780823